| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06908304 | A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC | NOT_YET_RECRUITING | PHASE3 | 2025-11-03 | 2027-07-29 | 2026-07-29 |
| NCT05208944 | THIO Sequenced With Cemiplimab in Advanced NSCLC | RECRUITING | PHASE2 | 2022-06-08 | 2026-12-31 | 2026-06-30 |